AFT Pharmaceuticals Limited (ASX:AFP)

Market Cap	248.04M
Revenue (ttm)	189.03M
Net Income (ttm)	10.87M
Shares Out	n/a
EPS (ttm)	0.10
PE Ratio	22.82
Forward PE	16.64
Dividend	0.02 (0.68%)
Ex-Dividend Date	Jun 18, 2025

Volume	3,161
Average Volume	1,553
Open	2.450
Previous Close	2.450
Day's Range	2.350 - 2.450
52-Week Range	2.150 - 3.160
Beta	0.36
RSI	48.76
Earnings Date	Aug 21, 2025

About AFT Pharmaceuticals

AFT Pharmaceuticals Limited, together with its subsidiaries, engages in the development, marketing, and distribution of pharmaceutical products in New Zealand, Australia, Asia, and internationally. The company offers products for use in the areas of allergy, gastrointestinal, cold and flu, digestive health, eye care, first aid, nail care, pain management, skin care, vitamins, and supplements, as well as other products. The company has collaboration with Belgium’s Hyloris Pharmaceuticals to develop a novel innovative injectable iron deficiency t...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1997
• Employees: 119
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: AFP

Financial Performance

In 2024, AFT Pharmaceuticals's revenue was 208.02 million, an increase of 6.45% compared to the previous year's 195.41 million. Earnings were 11.96 million, a decrease of -23.36%.

Financial numbers in NZD